James P. Coyle - 20 Feb 2026 Form 4 Insider Report for OPENLANE, Inc. (OPLN)

Role
EVP & President, Marketplace
Signature
Charles S. Coleman as Attorney-In-Fact
Issuer symbol
OPLN
Transactions as of
20 Feb 2026
Net transactions value
-$2,760,261
Form type
4
Filing time
23 Feb 2026, 17:56:15 UTC
Previous filing
20 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coyle James P EVP & President, Marketplace C/O: OPENLANE, INC., 11299 NORTH ILLINOIS STREET, CARMEL Charles S. Coleman as Attorney-In-Fact 23 Feb 2026 0001891323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPLN Common Stock Options Exercise $259,321 +17,689 +28% $14.66 81,558 20 Feb 2026 Direct
transaction OPLN Common Stock Sale $510,328 -17,689 -22% $28.85 63,869 20 Feb 2026 Direct F1
transaction OPLN Common Stock Options Exercise $1,037,268 +70,755 +111% $14.66 134,624 20 Feb 2026 Direct
transaction OPLN Common Stock Sale $2,039,159 -70,755 -53% $28.82 63,869 20 Feb 2026 Direct F2
transaction OPLN Common Stock Options Exercise $0 +16,730 +26% $0.000000 80,599 21 Feb 2026 Direct F3
transaction OPLN Common Stock Tax liability $210,774 -7,362 -9.1% $28.63 73,237 21 Feb 2026 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPLN Restricted Stock Units Options Exercise $0 -16,730 -33% $0.000000 33,462 21 Feb 2026 Common Stock 16,730 Direct F5, F6
transaction OPLN Employee Stock Option (right to buy) Options Exercise $259,321 -17,689 -100% $14.66 0 20 Feb 2026 Common Stock 17,689 $14.66 Direct F7
transaction OPLN Employee Stock Option (right to buy) Options Exercise $1,037,268 -70,755 -50% $14.66 70,755 20 Feb 2026 Common Stock 70,755 $14.66 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.72 to $28.96 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.56 to $29.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Each restricted stock unit is convertible into a share of common stock on a 1-for-1 basis. The restricted stock units vested in common stock on February 21, 2026.
F4 Shares withheld by the Company to satisfy tax withholding requirements.
F5 Each restricted stock unit is convertible into a share of common stock on a 1-for-1 basis.
F6 These restricted stock units remain subject to a time-vesting requirement and are scheduled to vest and settle in common stock as follows: one-third of these restricted stock units vested on February 21, 2026, one-third of these restricted stock units vest on February 21, 2027 and the remaining one-third of these restricted stock units vest on February 21, 2028, assuming continued employment through the applicable vesting date.
F7 These options were granted on November 5, 2021 and vested and became exercisable in equal installments on each of the first four anniversaries of the grant date, and were subject to continued employment through such vesting date.
F8 These options were granted on November 5, 2021 and become eligible to vest and become exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $19.66, $24.66, $29.66, and $34.66, for twenty consecutive trading days, subject to continued employment through such vesting date.